产品特点
Issued: September 2013
AN: 00700/2012
Page 1 of 6
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Felimazole 1.25 mg Coated Tablets for Cats
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
1 tablet contains:
Active substance:
Thiamazole
1.25 mg
Excipients:
Titanium Dioxide (E171)
0.51 mg
Dispersed Ponceau 4R Lake (E124)
1.35 mg
For a full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Coated tablet.
Red sugar-coated biconvex tablets 5.5 mm diameter.
4.
CLINICAL PARTICULARS
4.1 TARGET SPECIES
Cats.
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For the stabilisation of hyperthyroidism in cats prior to surgical thyroidectomy.
For the long-term treatment of feline hyperthyroidism.
4.3 CONTRAINDICATIONS
Do not use in cats suffering from systemic disease such as primary liver disease or
diabetes mellitus.
Do not use in cats showing signs of autoimmune disease.
Do not use in animals with disorders of white blood cells, such as neutropenia and
lymphopenia.
Do not use in animals with platelet disorders and coagulopathies (particularly
thrombocytopenia).
Do not use in cats with hypersensitivity to thiamazole or the excipient, polyethylene
glycol.
Do not use in pregnant or lactating females.
Please refer to section 4.7.
Issued: September 2013
AN: 00700/2012
Page 2 of 6
4.4 SPECIAL WARNINGS
As thiamazole can cause haemoconcentration, cats should always have access to
drinking water.
4.5 SPECIAL PRECAUTIONS FOR USE
Special precautions for use in animals
If more than 10 mg per day is required animals should be monitored particularly
carefully.
Use of the product i
阅读完整的文件